Peptidic Scaffolds To Reduce the Interaction of Cu(II) Ions with ß-Amyloid Protein.
Inorg Chem
; 59(1): 837-846, 2020 Jan 06.
Article
em En
| MEDLINE
| ID: mdl-31855423
ABSTRACT
Competitive Cu(II)-binding studies have been carried out between five decapeptides (both acyclic and cyclic), namely C-Asp, C-Asn, O-Asp, ODPro-Asp, and O-Asn, and the Aß(1-16) and Aß(1-40) fragments. Conformational constraints in such peptidic scaffolds affect their copper-binding affinity, which can be tuned. In the present study, the ability of these peptides to compete with Aß has been assessed in vitro, with the objective to examine whether such soft chelating agents may be used to lessen the deleterious interaction of Cu(II) with Aß. Fluorescence spectroscopy, electron paramagnetic resonance, and mass spectrometry data show that the more constrained peptide, i.e., cyclic C-Asp, which displays a Cu(II)-binding affinity comparable to that of Aß, is the only potential metal-protein attenuating compound (MPAC) candidate. In vitro aggregation studies with Aß(1-40) reveal that C-Asp can hamper the formation of copper-stabilized oligomeric Aß species, through capturing the metal ion prior to its interaction with monomeric Aß. The present study shows that (cyclic) peptides, preorganized for Cu(II) binding, may be applied for the development of potential copper-Aß attenuating compounds.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Peptídeos Cíclicos
/
Peptídeos beta-Amiloides
/
Cobre
Idioma:
En
Revista:
Inorg Chem
Ano de publicação:
2020
Tipo de documento:
Article
País de afiliação:
Espanha